561 related articles for article (PubMed ID: 29325226)
1. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Grilz E; Mauracher LM; Posch F; Königsbrügge O; Zöchbauer-Müller S; Marosi C; Lang I; Pabinger I; Ay C
Br J Haematol; 2019 Jul; 186(2):311-320. PubMed ID: 30968400
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism.
Rosell A; Gautam G; Wannberg F; Ng H; Gry H; Vingbäck E; Lundström S; Mackman N; Wallén H; Westerlund E; Thålin C
J Thromb Haemost; 2023 Nov; 21(11):3166-3174. PubMed ID: 37479035
[TBL] [Abstract][Full Text] [Related]
4. Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.
Smith P; Rosell A; Farm M; Bruzelius M; Aguilera Gatica K; Mackman N; Odeberg J; Thålin C
PLoS One; 2022; 17(7):e0270865. PubMed ID: 35901107
[TBL] [Abstract][Full Text] [Related]
5. The impact of neutrophil extracellular traps on deep venous thrombosis in patients with traumatic fractures.
Liu L; Zhang W; Su Y; Chen Y; Cao X; Wu J
Clin Chim Acta; 2021 Aug; 519():231-238. PubMed ID: 34015302
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
7. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
8. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
Hisada Y; Mackman N
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.
Savchenko AS; Martinod K; Seidman MA; Wong SL; Borissoff JI; Piazza G; Libby P; Goldhaber SZ; Mitchell RN; Wagner DD
J Thromb Haemost; 2014 Jun; 12(6):860-70. PubMed ID: 24674135
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
12. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
13. Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma.
Thålin C; Daleskog M; Göransson SP; Schatzberg D; Lasselin J; Laska AC; Kallner A; Helleday T; Wallén H; Demers M
Immunol Res; 2017 Jun; 65(3):706-712. PubMed ID: 28161762
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Ay C; Simanek R; Vormittag R; Dunkler D; Alguel G; Koder S; Kornek G; Marosi C; Wagner O; Zielinski C; Pabinger I
Blood; 2008 Oct; 112(7):2703-8. PubMed ID: 18539899
[TBL] [Abstract][Full Text] [Related]
15. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
16. Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis.
Bryk AH; Prior SM; Plens K; Konieczynska M; Hohendorff J; Malecki MT; Butenas S; Undas A
Cardiovasc Diabetol; 2019 Apr; 18(1):49. PubMed ID: 30992036
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.
Hisada Y; Grover SP; Maqsood A; Houston R; Ay C; Noubouossie DF; Cooley BC; Wallén H; Key NS; Thålin C; Farkas ÁZ; Farkas VJ; Tenekedjiev K; Kolev K; Mackman N
Haematologica; 2020 Jan; 105(1):218-225. PubMed ID: 31048354
[TBL] [Abstract][Full Text] [Related]
18. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
Grilz E; Marosi C; Königsbrügge O; Riedl J; Posch F; Lamm W; Lang IM; Pabinger I; Ay C
J Thromb Haemost; 2019 Aug; 17(8):1335-1344. PubMed ID: 31099477
[TBL] [Abstract][Full Text] [Related]
19. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
Simanek R; Vormittag R; Ay C; Alguel G; Dunkler D; Schwarzinger I; Steger G; Jaeger U; Zielinski C; Pabinger I
J Thromb Haemost; 2010 Jan; 8(1):114-20. PubMed ID: 19889150
[TBL] [Abstract][Full Text] [Related]
20. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
